Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Phase I/II Trial for Patients with Recurrent Resectable Glioblastoma Multiforme Using Surgery with Implantable BCNU Polmer Followed by Post-operative Irinotecan and Bevacizumab

		Keywords:		Bevacizumab

		Phase:		Phase 1/2

		Treatment ID#s:		VT1935

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		08/27/2009

		Tumor Types:		Glioblastoma Multiforme


		Comments:

		Treatment Type:		Surgery Chemotherapy.

		Contact:		UC Brain Tumor Center Alison Kastl, BS Director of Clinical Trials 234 Goodman Street Cincinnati, OH 45219 Phone:513-584-7698 Fax: 513-584-5680 Click here to send an email Website: ucbraintumorcenter.com

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By